Question 1

Who are the top researchers at Infusion Associates?

Accepted Answer

Ranked on the quality score, Khan J. Nedd lead among researchers whose main affiliation is Infusion Associates.

Question 2

What are the most cited papers from Infusion Associates?

Accepted Answer

The most cited paper from Infusion Associates is "Treatment of Fabry’s Disease with the Pharmacologic Chaperone Migalastat" (Dominique Paul Germain et al., 2016), with 566 citations. Next come "Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study" (395) and "Long-term efficacy and safety of migalastat treatment in Fabry disease: 30-month results from the open-label extension of the randomized, phase 3 ATTRACT study" (81).

Question 3

Which research topics does Infusion Associates publish most on?

Accepted Answer

By volume in 2022-now: Lysosomal Storage Disorders Research, Data Analysis with R, Scientific Computing and Data Management and Intravenous Infusion Technology and Safety.

Question 4

Which fields of science does Infusion Associates work in?

Accepted Answer

In all years, 59% of research at Infusion Associates is in Health Sciences, 16% in Life Sciences. Its largest fields are Medicine (55%), Immunology and Microbiology (11%), Engineering (6%). It does 1.7× the world's share of Health Sciences.

Question 5

Is Infusion Associates's research output growing?

Accepted Answer

Output in 2022-2025 was 185% higher than in 2018-2021.